SEARCH RESULTS FOR:

Mining
Colombia

Eduardo Cossio Chirinos

CEO, INCIMMET
INCIMMET explains why it is focusing on growth in the Colombian mining industry.
Mexico
Petrochemicals & Chemicals

Abraham Klip Moshinsky

DIRECTOR GENERAL, UNIGEL MEXICO
Unigel has enjoyed a successful year in Mexico.
Mining
Canada

Hon. Greg Rickford

MINISTER OF ENERGY, MINES, NORTHERN DEVELOPMENT AND INDIGENOUS AFFAIRS, GOVERNMENT OF ONTARIO
Ontario’s Minister of Mines explains what his ministry did wrong during 2020 and also what they have set right to ensure mines lead Ontario’s recovery.
Mining
Zambia
DRC
Angola
MACIG

MACIG Copperbelt & Angola 2021

Mining
Canada

John McCluskey

PRESIDENT & CEO, ALAMOS GOLD
Alamos Gold explains how it protected its operations from COVID-19 and the progress at its Canadian and Mexican gold mines.
Mining
Ghana
MACIG

Serigne Ndanck Mbaye

CEO WEST AFRICA & COUNTRY HEAD GHANA, DHL
DHL West Africa explains how they were able to serve their customers in Africa throughout the pandemic.
Petrochemicals & Chemicals
Singapore

Vinod Agnihotri

MANAGING DIRECTOR ASEAN, HEAD OF MPP – ASIA PACIFIC, LANXESS
Lanxess Asia Pacific explains how specialisation, digitalisation and environmental sustainability drive growth.
Mining
Ghana
MACIG

Joseph Titus Glover

CEO, QUANTUM LC
Quantum LC describes an increasingly competitive market for mining services in Ghana but believes that local companies can succeed.
Petrochemicals & Chemicals
Singapore

Gabriele Unger

GENERAL MANAGER, TOGETHER FOR SUSTAINABILITY (TFS)
Together for Sustainability (TfS) is expanding its efforts and reach in ensuring a sustainable supply chain for the global chemical industry.
Mining
Peru

Carlos Leigh

CEO – LATIN AMERICA, DSI UNDERGROUND
DSI Underground discusses the recovery in mining activity in Latin America following lockdowns.

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

United States Life Sciences 2025 - Digital Interactive

Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
MORE PREVIOUSLY PUBLISHED

PARTNER EVENTS

SEE ALL